Annelies Stevaert

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

Journal: Microbiology spectrum

Published: June 15, 2026

Structure-activity relationship and nsp15-dependent mechanism of spirothiazolidinone derivatives with pan-coronavirus activity.

Structure-activity relationship and nsp15-dependent mechanism of spirothiazolidinone derivatives with pan-coronavirus activity.

Journal: Bioorganic chemistry

Published: January 23, 2026

N-[(Thiophen-3-yl)methyl]benzamides as Fusion Inhibitors of Influenza Virus Targeting H1 and H5 Hemagglutinins.

N-[(Thiophen-3-yl)methyl]benzamides as Fusion Inhibitors of Influenza Virus Targeting H1 and H5 Hemagglutinins.

Journal: Journal of medicinal chemistry

Published: August 29, 2025

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy against Corona and Influenza Viruses.

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy against Corona and Influenza Viruses.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 09, 2025

A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses.

A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses.

Journal: PLoS pathogens

Published: September 06, 2024

Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.

Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.

Journal: American journal of respiratory and critical care medicine

Published: June 12, 2024

Exploration of isatin-based inhibitors of SARS-CoV-2 Nsp15 endoribonuclease.

Exploration of isatin-based inhibitors of SARS-CoV-2 Nsp15 endoribonuclease.

Journal: European journal of medicinal chemistry

Published: May 20, 2024

The coronavirus nsp15 endoribonuclease: A puzzling protein and pertinent antiviral drug target.

The coronavirus nsp15 endoribonuclease: A puzzling protein and pertinent antiviral drug target.

Journal: Antiviral research

Published: April 12, 2024

A coronavirus assembly inhibitor that targets the viral membrane protein.

A coronavirus assembly inhibitor that targets the viral membrane protein.

Journal: Nature

Published: April 06, 2024

Exploration of 1,2,3-triazolo fused triterpenoids as inhibitors of human coronavirus 229E targeting the viral nsp15 protein.

Exploration of 1,2,3-triazolo fused triterpenoids as inhibitors of human coronavirus 229E targeting the viral nsp15 protein.

Journal: Archiv der Pharmazie

Published: August 13, 2023

PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.

PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding.

Journal: Antiviral research

Published: June 02, 2023

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface.

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface.

Journal: International journal of molecular sciences

Published: April 06, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026